Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Acute Confusional Senile Dementia

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Acute Confusional Senile Dementia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clark, DB; Coupal, JJ; Dekosky, ST; Kung, HF; Pulmano, C; Ryo, UY; Shih, WJ; Simmons, G1
Brittain, HM; Demyer, MK; Farlow, MR; Hall, KS; Hendrie, HC; Wellman, HN1

Other Studies

2 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Acute Confusional Senile Dementia

ArticleYear
I-123 hydroxyiodobenzyl propanediamine (HIPDM) cerebral blood flow imaging demonstrating transtentorial diaschisis.
    Clinical nuclear medicine, 1990, Volume: 15, Issue:9

    Topics: Alzheimer Disease; Brain; Cerebral Infarction; Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Iodine Radioisotopes; Iodobenzenes; Tomography, Emission-Computed, Single-Photon

1990
Single photon emission tomographic brain images in dementia of the Alzheimer type.
    The American journal of psychiatry, 1987, Volume: 144, Issue:3

    Topics: Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Humans; Iodobenzenes; Middle Aged; Tomography, Emission-Computed

1987